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Abstract
A yearlong eld experimental campaign was conducted to reveal time
scales over which antibiotic uxes vary in the inuent of a wastewater treat-
ment plant (WTP). In particular, sampling was carried out to ascertain the
amplitudes of monthly, daily and hourly uctuations of several antibiotics.
A total of 180 samples was collected at the entrance of a WTP in Lausanne,
Switzerland. Sample concentrations were multiplied by ow rate to obtain
monthly, daily and hourly mass uxes of six antibiotics (trimethoprim, nor-
oxacin, ciprooxacin, ooxacin, clindamycin and metronidazole). Seasonal-
ity in mass uxes was observed for all substances, with maximum values in
winter being up to an order of magnitude higher than in summer. The hourly
measurements of the mass ux of antibiotics were found to have a period of
12 h. This was due to peaks in toilet use in the morning and early evening. In
particular, the morning peak in ushing coincided with high concentrations
(and hence high mass uxes) due to overnight accumulation of substances
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in urine. However, little variation was observed in the average daily ux.
Consequently, uctuations in mass uxes of antibiotics were mainly evident
at the monthly and hourly time scales, with little variation on the day-week
time scale. These results can aid in optimizing removal strategies and future
sampling campaigns focused on antibiotics in wastewater.
Keywords: Pharmaceuticals, Water quality, Mass loading, Sampling, Time
scale, Fluctuation
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1. Introduction1
Although the quality of natural waters has been investigated extensively,2
continuing eorts are directed to understand better the complex dynamics3
of wastewater discharges to the environment. The most studied and best4
treated wastewater pollutants are organic materials and nutrients. On the5
other hand, the origin and fate of emerging pollutants, also referred as mi-6
cropollutants, are still insuciently understood (Ternes and Joss, 2006; Ver-7
licchi et al., 2012). There is a plethora of micropollutants, each of which8
potentially displays dierent behavior in the environment (Kleywegt et al.,9
2011; Rimkus, 1999). Here, we examine the dynamics of antibiotic mass10
uxes in a wastewater treatment plant (WTP) inuent.11
Antibiotics have been measured in WTP inuents worldwide (Hirsch12
et al., 1999; Kummerer, 2009; Tamtam et al., 2008). They are suspected to13
present an environmental risk, e.g., fostering bacterial resistance (Czekalski14
et al., 2010; Servais and Passerat, 2009). For this reason, antibiotics in ur-15
ban systems and discharges have been subject to increased investigation in16
the last decade (Neu, 1992; Pruden et al., 2006; Verlicchi et al., 2012). Sev-17
eral studies have reported evidence of seasonal uctuations in concentra-18
tions of various antibiotics in WTPs and in natural waters (Conley et al.,19
2008; Gobel et al., 2005; Lissemore et al., 2006; Santos et al., 2009). The20
changing wastewater characteristics and imposition of stricter wastewater21
discharge regulations have led to a greater emphasis on WTP inlet uxes22
(Tchobanoglous et al., 2003). Process modeling of activated sludge dynam-23
ics is becoming increasingly important, as is the characterization of the dy-24
namics of WTP inuent (Hulsbeek et al., 2002). The temporal dynamics of25
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ammonia and dissolved organic carbon for instance have already been well26
described (Tchobanoglous et al., 2003). However, there are few studies that27
assess the time variability of antibiotics. In Table 1, we summarize existing28
studies reporting antibiotic dynamics at WTP inlets.29
In a paper aiming to assess the removal of pharmaceuticals and fragrances30
in a WTP, Joss et al. (2005) observed some uctuations in antibiotic con-31
centrations at the WTP inlet, but the sampling methodology (8-h composite32
samples, Table 1) was insucient to determine details of the inuent dy-33
namics. In another study, Plosz et al. (2010) measured the diurnal variation34
of hormones and antibiotics in activated sludge wastewater, as part of their35
overall goal of linking posology and observed concentrations. However, sim-36
ilarly to Joss et al. (2005), Plosz et al. (2010) used 8-h composite samples37
taken after the primary clarier to assess the temporal variability (Table 1).38
That is, in both studies, the authors collected three 8-h composite samples39
per day. Plosz et al. (2010) had a total of nine samples (3 sampling days)40
whereas Joss et al. (2005) sampled for 1 d giving a total of three samples. In41
both cases, the sampling frequency (3 per day) and the total number of sam-42
ples are insucient to identify diurnal variability. Gerrity et al. (2011) and43
Teerlink et al. (2012) identied a diurnal pattern consisting of two mass ux44
peaks in WTP inuent, one in the morning followed by a lower peak during45
the night (Table 1). Salgado et al. (2011) investigated day-to-day variation of46
chemicals and measured a load of pharmaceuticals that surprisingly varied47
by an order of magnitude from one day to the next. These authors con-48
cluded that the dynamics of pharmaceuticals needed further investigation to49
understand the variability in more detail.50
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Table 1 near here51
The studies listed in Table 1 generally observed a peak in morning con-52
centrations. This observation is not surprising as antibiotics and other sub-53
stances ingested during the evening accumulate in urine during sleep (Noh54
et al., 2011; Pandi-Permural and Cardinali, 2007). However, all the cited55
studies were not designed to examine the temporal variability of antibiotics56
in WTP inuent in a systematic way (i.e., over dierent time scales). In this57
work, our objective was to uncover time scales in mass uxes of represen-58
tative antibiotics in WTP inuent. To this end, we performed a yearlong59
on-site experimental campaign with sucient sampling to capture hourly to60
seasonal uctuations. Besides its scientic interest, the study has the poten-61
tial to help in the optimization of micropollutant removal in WTPs. More62
particularly, the results will underpin the design of future sampling cam-63
paigns focusing on antibiotics, as well as the interpretation of data sets, e.g.,64
short-term sampling campaigns.65
2. Materials and Methods66
2.1. Sample collection67
A yearlong study was conducted at the Vidy WTP, in Lausanne, Switzer-68
land. The WTP collects wastewater for approximately 220,000 inhabitants,69
and several hospitals. The latter contribute about 1% of the total wastew-70
ater volume of reaching the WTP. The automatic sampler was installed at71
the entrance of the WTP, upstream of the primary settling tank, in order to72
capture the dynamics of the mass ux of incoming antibiotics. Starting in73
5
March 2011, 12 (i.e., once each month) weeklong sampling campaigns were74
conducted. These campaigns consisted of seven daily-composite samples,75
collected for the seven consecutive days (84 samples collected in total). A76
daily-composite sample was obtained by mixing (ow proportionally) 24 indi-77
vidual (hourly) 200-ml samples collected with an automatic sampling device78
(6712FR Teledyne ISCO). Collected samples were stored on-site in plastic79
bottles inside a refrigerated sampling device at a temperature below 4C be-80
fore collection for laboratory analysis. Samples were analyzed or frozen at81
-20C within 24 h after collection.82
In addition to the yearlong campaign, four 24-h campaigns were con-83
ducted to evaluate the dynamics at the hourly scale. The four campaigns84
were conducted during four dierent months: December, May, September85
and November. Each 24-h campaign provided 24 samples (96 in total), one86
per hour, starting at 07:00. Each hourly sample was the aggregation of four87
200-ml wastewater samples collected every 15 min.88
The dierent eld campaigns are summarized in Table 2. All samples were89
collected at the same location using the same sampler. Water samples were90
analyzed using online SPE UPLC-MS/MS, and concentrations were obtained91
for six antibiotics | trimethoprim, noroxacin, ciprooxacin, ooxacin, clin-92
damycin, metronidazole | for a total of 1080 analyses. These six antibiotics93
were classied has priority substances based on physico-chemical characteris-94
tics in a previous study (Coutu et al., 2012) and because they were measured95
in Vidy Bay, where the WTP discharges its euent (Bonvin et al., 2011).96
The sampling program allows comparison of mass ux uctuations month-97
to-month, day-to-day and hour-to-hour, thereby providing information on the98
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time scales that control antibiotic uxes in wastewater.99
Table 2 near here100
2.2. Flow measurements101
An ultrasonic sensor was installed next to the automatic sampler to record102
water levels at 5-min intervals. The water level was later converted into ow103
by use of the appropriate calibration1. All water ow data can be found in104
the Supplementary data.105
2.3. Sample treatment and chemical analysis106
As a rst step samples were acidied to pH 2-2.5 with hydrochloric acid107
(concentrated 25%). Then, samples were ltered, rst, through 2.7-m glass108
ber pre-lters (type GF/D, Whatman). The pre-ltered samples were l-109
tered again through 0.45-m membrane lters (type ME 25, mixed cellulose110
ester, Whatman). Samples were stored at -20C until analysis.111
The analytical method involved online solid-phase extraction (SPE) and112
Ultra Performance Liquid Chromatography coupled with tandem mass spec-113
trometer (Xevo UPLC-MS/MS, Waters). Frozen samples were thawed to114
room temperature prior to analysis. Then, 8 mL of each sample was l-115
tered through 0.2-m syringe lters (type GMF, BGB-analytik) directly into116
the injection vials. A mixture of deuterated antibiotic surrogates was added117
with a gas-tight syringe into all injection vials (samples as well as standards).118
Targeted compounds were rst extracted in the online SPE system, which119
1http://www.isco.com, site last accessed in June 2012
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consisted of a 2:120 mm SPE column (type Oasis HLB 25 m, Waters).120
Extracted compounds were separated in a 2:1  50 mm chromatographic121
analytical column (type Acquity UPLC BEH C18 1.7 m, Waters) with an122
organic mobile phase in gradient mode. All the targeted compounds were123
identied and quantied using tandem mass spectrometry according to their124
masses of precursor and product ions as well as their mass-to-charge ratios.125
More information on mobile phases and HPLC gradient used can be found126
in the supplementary materials.127
The analytical limit of quantication (LOQ) was dened as the concen-128
tration of the lowest standard with a signal-to-noise ratio greater than 10129
(Bonvin et al., 2011). The antibiotic concentration in the samples was calcu-130
lated based on calibration curves using seven calibration points closest to the131
sample concentration. Correlation coecients for the calibration curves were132
typically 0.99 at least. In the calculation of sample concentration, recovery133
rates of deuterated surrogates and exact sample mass weighed during sample134
preparation were taken into account for each associated antibiotic compound.135
Details of the precision of the method are summarized in Table 3.136
2.4. Data analysis137
We discuss mass uxes of antibiotics rather than concentrations, since138
dilution occurs during rainy periods. Mass uxes, or load, to the WTP139
is useful when dierent sites are compared (Johnson, 2010). Hereafter, we140
use the term \measured mass ux" to indicate the mass ux obtained by141
multiplying, for each sample, the measured ow and measured concentration.142
Statistical techniques were used to assess potential temporal character-143
istics in mass ux uctuations and the variability at dierent time scales144
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(month, day, hour: m, d, h) in the mass ux of antibiotics at the WTP inlet.145
Calculations were carried out using Matlab2. Standard statistical tests were146
performed (mean, median and dierent percentiles of the measured mass147
uxes). In addition, the periodogram of the 96 hourly values was extracted148
to identify possible periodicity in the hourly dynamics. This was done by149
windowing the data using the technique of Welch (1967), after which the150
periodogram was computed using the fast Fourier transform.151
3. Results and Discussion152
3.1. Seasonality of mass ux153
Mass uxes measured monthly at the WTP inlet are compared. Seven154
consecutive daily samples were aggregated ow proportionally to form a155
monthly sample (Table 2). The median mass ux obtained is presented for156
each month and all substances in Figure 1. Minimum monthly mass uxes are157
generally found during the period running from June to September. Mass158
uxes measured in December and January have systematically higher val-159
ues except for ciprooxacin. High values are also observed in March for160
ciprooxacin, ooxacin and clindamycin. Note that an error in the experi-161
mental procedure meant that unfortunately we could not retrieve mass uxes162
for the month of February.163
In comparing the dierent time series of mass uxes, data for a given time164
scale were normalized by the appropriate mean calculated for the considered165
data. Thus, hourly, weekly and monthly data were normalized by daily,166
2Matlab 2009b, The Mathworks, Natick, Massachusetts, USA
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monthly and annual means, respectively. This allows comparison of varia-167
tions in data sets with dierent means. For example, the monthly mass ux168
normalized by the annual mean is helpful to evaluate the seasonality of the169
dierent antibiotics, as well as the range of the month-to-month uctuations.170
This relative uctuation is presented in Figure 3a for the six antibiotics. The171
normalized monthly mass uxes range between a quarter and double of the172
mean annual mass ux measured at the WTP inlet. Obvious seasonality173
is observed in the mass uxes of ciprooxacin, ooxacin and clindamycin,174
with winter values being up to eight times greater than corresponding sum-175
mer values. Trimethoprim, on the other hand, shows less variability in the176
monthly mass ux over the year, although a higher mass ux is still observed177
in January and December. The behavior of noroxacin and metronidazole178
is somewhat peculiar; values of monthly mass uxes are located broadly be-179
tween a quarter and half of the mean, with a sudden rise in December and180
January. For all substances we observe that the highest mass ux is measured181
during the (winter) months of December and January.182
The boxplot widths appear to be signicant for some substances in Fig-183
ure 1 (e.g., noroxacin in January). This indicates that successive daily mass184
uxes within a week were not constant, which should be the case for antibi-185
otics (see x.3.3). This variability reects the random nature of the inputs186
into the sewer system, as well as uncertainty in the measurements, which in187
the case of UPLC/MS-MS can be reasonably considered to range up to 20%188
(Bonvin et al., 2011).189
Figure 1 near here190
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The clear seasonality in the observed mass ux of ciprooxacin (Figure 1)191
can be explained by considering its therapeutic use. Ciprooxacin is mainly192
prescribed to treat seasonal diseases like airway infections (i.e., bronchitis and193
pneumonia) and infections aecting the throat, nose and ears (pharyngitis,194
sinusitis, earache). The mass ux of noroxacin is also aected by seasonality.195
It is also used to treat similar seasonal pathologies, albeit to a lesser extent196
than ciprooxacin. In contrast, trimethoprim displays reduced seasonality197
in mass uxes, corresponding to its use for non-seasonal diseases, typically198
urinary-genital tract infections. However, the connection between seasonality199
in prescriptions to that in mass ux is not systematic. Indeed, ooxacin200
displays seasonality in mass ux dynamics, yet it is used to treat non-seasonal201
pathologies like skin or urinary-genital tract infections. It is thus dicult202
to explain seasonality (or lack thereof) in mass uxes of specic compounds.203
Possibly, seasonal temperature changes are sucient to inuence degradation204
of some compounds while they are transported in the sewer system.205
3.2. Periodicity in hourly mass ux206
The four 24-h campaigns described in Table 2 were used to evaluate peri-207
odicity in the mass ux of antibiotics reaching the WTP during dry weather.208
For this, the measured hourly mass ux was rst normalized to the mean for209
that day (Figure 3c). After normalization, data from the four 24-h campaigns210
were combined sequentially into a series of 96 experimental values. The pe-211
riodogram for ciprooxacin is shown in Figure 2. Periodograms for the ve212
other antibiotics considered in this study can be found in the Supplementary213
data.214
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Figure 2 near here215
For all substances considered, two noticeable peaks appear in the com-216
puted periodogram, which indicates that the mass ux of antibiotics has a217
12-h period. According to Figure 3c, the rst peak occurs between 07:00 and218
09:00. The magnitude of this morning peak is up to double that of the aver-219
age daily ux reaching the WTP. It corresponds to the peak in toilet ushes220
observed by Friedler et al. (1996) and Rauch et al. (2003). The second peak221
occurs 12 h later, between 17:00 and 21:00. This peak is less pronounced222
than the morning peak, and occurs over a broader period. Its maximum is223
around 1.2 times the daily mean, except for metronidazole.224
Consistent with previous observations, the uctuations in the mass ux225
of antibiotics are greater than those of the ow rate (Figure 3c). Plosz et al.226
(2010) explained that the high peak in pharmaceutical load at the WTP in-227
let is due to posology. Antibiotics are typically administrated every 8 or 12228
h, with one ingestion occurring in late evening. During sleep, the antibiotic229
accumulates in urine and is released in the rst toilet ush of the morning.230
Concentrations are thus relatively high, leading to the observed dierence in231
uctuations. A second peak in the mass ux, lower than the rst, occurs ap-232
proximately 12 h later (Figure 2 and 3c). This second peak was not observed233
by Plosz et al. (2010) as they used 8-h composite samples. The reduction in234
the magnitude of this peak results again from posology. Indeed, the posol-235
ogy of antibiotics is calculated so that they are metabolized at a constant236
rate. Due to more frequent toilet use during daytime, the concentration in237
the urine is, ideally, constant. Thus, the second peak observed is due to the238
corresponding increase in wastewater volume. For this reason the increase in239
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mass ux of antibiotics and ow rate are in the same range (Figure 3c).240
3.3. Dominant time scale241
Mean normalized mass uxes were used to compare the temporal dy-242
namics of antibiotics at dierent time scales. The results are summarized in243
Figure 3. We observe that whereas monthly and hourly mean mass uxes244
uctuate between 0.25 and 2 times the corresponding mean (the annual mean245
and daily mean, respectively), very little uctuation is observed at the daily246
scale (Figure 3b). All daily measured mass uxes remain located between247
20% of the weekly average, the only exception being metronidazole. A248
day-to-day variability in the usage of this last substance could be responsi-249
ble for the observed variability at the WTP entrance (between 2.2 and 0.3250
times the mean daily load ux, see Figure 3b). Indeed, some pathologies are251
treated by a single high dose of this compound (e.g., bacterial vaginosis, 2 g252
of metronidazole) (CDC, 2002). Depending on the number of people treated,253
these \single pulses" may explain the observed variability at this time scale.254
More medical data on the occurrence of these kind of diseases would help to255
characterize this behavior.256
Figure 3 near here257
Figure 4 near here258
The dominance of variability in antibiotic mass uxes at the monthly and259
hourly time scales over that at the daily time scale is illustrated in Figure 4.260
The variability of the daily mass ux (during the week) is systematically261
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lower than that of the monthly mass ux considered over the year, or hourly262
mass ux over a day. Depending on the month or the hour of the sampling,263
the range of mass uxes varies by up to an order of magnitude. This is264
due to two factors. First, antibiotic consumption is seasonal, thus so are265
the corresponding mass uxes at the WTP entrance (Vernaz et al., 2008).266
Second, on the hourly time scale (during a given day), mass ux variability267
can be (partially) explained by toilet use frequency and the posology of the268
dierent antibiotics. These variations highlight the importance of the design269
of sampling campaigns for antibiotics in the environment Ort et al. (2010).270
3.4. Comparison with existing studies271
Comparisons of these results with existing studies is not straightforward272
as dierent analytical methods have been employed. In addition, there is273
variability in use of antibiotics and water between regions (Filippini et al.,274
2006).275
Santos et al. (2009) conducted a 1-y eld campaign at a WTP entrance276
to assess the dynamics of some micropollutants (not antibiotics). No clear277
pattern in the dynamics of the substances considered could be identied278
except for ibuprofen, where the authors suspected some seasonality. How-279
ever, ibuprofen is an anti-inammatory drug and seasonality in its use seems280
unlikely, especially when contrasted with antibiotics used to treat seasonal281
diseases such as airway infections (i.e., bronchitis and pneumonia) and in-282
fections aecting the throat, nose and ears (pharyngitis, sinusitis, earache).283
For the Lausanne WTP, ciprooxacin shows the clearest seasonality, with the284
mass ux in winter being up to 4 times greater than that measured during285
summer.286
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Gobel et al. (2005) assessed the seasonality of dierent antibiotics by com-287
paring three weekly campaigns conducted in March, September, November288
and February (see Table 1) in Eastern Switzerland. Loads observed at the289
WTP inlet were generally higher in February and March than in Septem-290
ber and November. This was explained by higher sales during these periods291
(sales data not provided) and, as mentioned above, by the seasonal use of292
these substances determined by the treated pathologies. Unfortunately, the293
number of samples collected was insucient to determine a clear pattern in294
seasonal uctuations of loads.295
Salgado et al. (2011) assessed diurnal variability of several pharmaceuti-296
cals (and other chemicals) in wastewater inuent. They sampled wastewater297
at a WTP inlet during two consecutive days (Monday-Tuesday), two weeks298
in a row. Ciprooxacin was measured on the two Tuesdays. A factor of299
two in mass load was observed, which was dicult to explain given that the300
sampling methodology and weather conditions were consistent for the two301
sampling days. By comparison, our results have clearer underpinnings, due302
to the nested temporal sampling employed. For antibiotics, where the patient303
follows a prescribed posology, the consumption over the whole WTP basin304
would vary little from one day to the next. Thus, the daily mass ux should305
remain within the same order of magnitude. Consistent with this reasoning306
are the ndings of Gerrity et al. (2011) and Huerta-Fontela et al. (2008), who307
found that compounds not subject to any posology (e.g., illicit products) do308
not follow this behavior.309
The diurnal variability of pharmaceuticals was recently the subject of a310
study conducted at a WTP inlet in Norway. Plosz et al. (2010) observed a311
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mass load up to three times greater in the morning than during the night312
for ciprooxacin and trimethoprim. A similar pattern was observed in other313
studies assessing the temporal dynamics of pharmaceuticals (Gobel et al.,314
2005; Joss et al., 2005). A second peak observed by Teerlink et al. (2012)315
and Gerrity et al. (2011) in the late afternoon was simply explained by a316
corresponding rise in ow rate at WTP inlet. However, it would be benecial317
to combine knowledge of posology, pharmacokinetics and toilet use frequency318
to obtain more insights on the hourly uctuations of these substances at the319
WTP inlet. A modeling study in that direction is currently underway in our320
group.321
4. Conclusion322
We have assessed the dominant time scale in the mass ux variability of323
several antibiotics in sewage water reaching the Vidy WTP. Mass uxes were324
observed to be higher in winter than in summer. This is particularly the325
case for ciprooxacin, with the winter mass ux being up to 3-4 times that326
in summer. These data are consistent with the hypothesis that the measure-327
ments reect the seasonal consumption of antibiotics, driven by associated328
seasonality in pathologies. However, further investigation is necessary to es-329
tablish a correlation between consumption and measured load to conrm this330
hypothesis.331
Little uctuation was observed on a day-to-day basis. This indicates that,332
at the scale of the WTP catchment area, daily consumption of antibiotics333
varies only slowly. Metronidazole was found to behave dierently, however,334
for reasons that are as yet unknown.335
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Diurnal uctuations in the mass ux of antibiotics show a similar trend336
for the six compounds investigated. Similarly to previous studies, a morning337
peak in mass ux was observed, which was not surprising as antibiotics accu-338
mulate overnight in the human body before being excreted in the morning.339
Another peak was generally observed 12 h later. Even though it is plausible340
that toilet use could explain this second peak, more knowledge on the phar-341
macokinetics of these antibiotics seems necessary to characterize more fully342
this mass ux increase.343
Several conclusions on sampling design of antibiotics in wastewater can be344
drawn out of the results of this study. First, the day of the week selected for345
sampling has no inuence on the load measured. Second, the seasonal con-346
sumption of the substance should be investigated when possible, as sizeable347
uctuations of mass ux of antibiotics can be observed at the WTP inlet.348
Third, at least an hourly sampling frequency and analysis are needed when349
the objective of the study is to assess the intra-day dynamics of antibiotics,350
in order to capture the morning and late afternoon mass ux peaks.351
More generally, posology, pharmacokinetics and toilet ush frequency352
control the mass ux of antibiotics in sewage water. These parameters should353
be accounted for when modeling the mass ux or concentrations in WTPs.354
The dataset presented here will aid such modeling eorts in the future.355
Supplementary data356
Supporting information is provided in the three les:357
 A1 (A1 ow.xlsx): A spreadsheet (Excel) le containing all ow values358
measured during the dierent experimental campaigns;359
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 A2 (A2 concentrations.xlsx): A spreadsheet (Excel) le containing all360
concentrations measured during the dierent experimental campaigns361
for each substance;362
 A3 (A3 periodo all): A PDF le with six gures representing the peri-363
odograms computed for the six antibiotics (cf. Figure 2);364
 A4 (A4 GradientMode.docx): A word le with additional technical365
notes on the experimental procedure.366
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Figure 1: Boxplots of mass uxes of the six antibiotics investigated (one box per month).
Each box was obtained from seven daily samples. Upper and lower box limits correspond
to the 75th and 25th percentiles, respectively. Upper and lower whiskers correspond to the
last datum being respectively still within 1.5IQR of the higher and lower quartile. IQR is
the interquartile range, i.e., the dierence between the upper and lower quartiles.
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Figure 2: Periodogram of the measured ciprooxacin hourly mass ux. Peaks in the power
spectrum observed at 0.042 h 1 and 0.083 h 1, which correspond to periods of 24 h and 12
h, respectively. The same periods were observed for the other substances (Supplementary
data).
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Figure 3: Fluctuations of mass ux at dierent time scales: month a), day b), and hour
c). In a), each symbol corresponds to the average mass ux of the seven daily samples
collected in the corresponding month. In b), each symbol corresponds to the average value
of the twelve times (one per month) the corresponding day was sampled. In c), each point
corresponds to the average of the four times (four 24-h campaigns) the corresponding hour
was sampled. Mass ux is normalized to mean mass ux over the considered time scale.
For example, in a) the monthly mass ux was normalized by the mean of the monthly
mass uxes measured over the year. Clear variability is observed at the monthly and
hourly time scales for all substances. No variability is observed at the daily time scale,
except for metronidazole. The corresponding ow | normalized to the mean ow over
the considered time scale | is shown on each graph by the blue line. The monthly mean
ow includes rainwater peaks in addition to baseow. Daily and hourly mean ows were
selected to include only dry periods, i.e., their uctuation is not aected by any rain input.
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Figure 4: Boxplots illustrating the dispersion of the measured mass uxes for the three
dierent time scales (m, d, h). Similar to Figure 3, the mass ux is normalized by the
mean mass ux over the considered time scale. For each substance, the box on the left is
obtained from the 12 mean monthly values (the 12 values in Figure 3a), the box in the
middle from the seven mean daily values (seven values in Figure 3b), and the box in the
right from the 24 mean hourly values (the 24 values in Figure 3c). Boxes were computed
following the same rule described in Figure 1.
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Table 1: Summary of studies assessing the temporal dynamics of antibiotics in WTP
inuent.
Study Antibiotic
Sampling regime at the
WTP inlet
Sampler
position
Joss et al. (2005)
Roxithromycin,
sulfamethoxazole
8-h composite samples of
primary euent taken during
one day
After primary
clarier
Gobel et al. (2005)
Sulfadiazine,
sulfathiazole,
sulfapyridine,
sulfamethoxazole,
trimethoprim,
erythromycin,
clarithromycin
Flow-proportional 8-h
composite sample during one
day plus three weekly
campaigns to assess
seasonality (three
ow-proportional composite
samples, one combining 24-h
integrated samples from
Saturday and Sunday and two
combining two or three
weekdays)
WTP inlet,
before clarier
Plosz et al. (2010)
Ciprooxacin,
trimethoprim,
sulfamethoxazole,
tetracycline
Three-day measurement
campaign. 8-h
ow-proportional composite
samples. Sampling frequency
of 15 min
After primary
clarier
Ort et al. (2010)
Chloramphenicol,
trimethoprim,
roxithromycin,
lincomycin,
erythromycin,
cephalexin, dapsone,
sulphadiazine
Tested several sampling
strategies and recommended a
5-min sampling frequency to
characterize intra-day
uctuations in WTP inuent
WTP inlet,
before clarier
Gerrity et al. (2011)
Trimethoprim,
sulfamethoxazole
Two 12-h campaigns with a
sampling frequency of 30 min
After primary
clarier
Salgado et al. (2011) Ampicillin
Two 48-h campaigns with a
sampling frequency of 2 h
WTP inlet,
before clarier
Teerlink et al. (2012)
Trimethoprim,
sulfamethoxazole
One 26-h campaign with a
sampling frequency of 1 h
WTP inlet,
before clarier
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Table 2: Description of the methodology used to obtain the monthly, daily and hourly
samples in the eld campaign. Samples were all collected at the same location at the Vidy
WTP entrance.
Type of sample Sample aggregation Number of samples Frequency
Monthly samples
Flow proportional average of
12 One per month
seven consecutive daily samples
Daily samples
200 ml samples collected
84
every hour during a day. 7 d (1 week)
The 24 samples were mixed ow per month
proportionally to get the daily average
Hourly samples
200 ml samples collected
96
Four 24 h
every 15 min during an hour. campaigns
Each hour, the four 200 ml samples (May, September,
were aggregated to form an hourly sample November, December)
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Table 3: Precision of the laboratory analysis.
Analyte
RSD (%)a
(R2)b LODc (ng/L) LOQd (ng/L) Recovery (%)e
Within one run
1 Trimethoprim 2 0.9993 1.3 4 881
2 Noroxacin 8 0.9827 1.3 4 11843
3 Ciprooxacin 1 0.9963 1.2 3.5 1057
4 Ooxacin 7 0.9959 1.2 3.5 9011
5 Clindamycin 1 0.9961 1.1 3.3 861
6 Metronidazole 4 0.9972 1 3 11622
aRelative Standard Deviation: concentrations detected in the samples during one con-
tinuous sequence of analysis. Three replicates were carried out
bCorrelation coecient with seven concentration levels. Noroxacin, ooxacin: 0.2 - 350
ng/L; trimethoprim, clindamycin: 0.3 - 630 ng/L and ciprooxacin, metronidazole: 0.4 -
700 ng/L
cLimit of detection calculated as a signal to noise (S/N) ratio of 3/1
dLimit of quantication calculated as a signal to noise (S/N) ratio of 10/1
eQuality control samples (three replicates) prepared in three injection vials for each
analyte with known concentrations of 3, 30 and 150 ng/L. Three replicates were carried out
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